Literature DB >> 28404684

The Immaculate Carbapenemase Study.

Kenneth S Thomson1.   

Abstract

Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and are typically resistant to most (sometimes all) antibiotics. We now face a global CPO pandemic of high mortality. In this issue of the Journal of Clinical Microbiology, Karlowsky et al. (J Clin Microbiol 55:1638-1649, 2017, https://doi.org/10.1128/JCM.02316-16) report the results of an extensive global surveillance study that provide much-needed information that enhances our understanding of carbapenemase-producing Enterobacteriaceae (CPE) and which will be valuable for the development of improved strategies for CPE control and therapy of infections.
Copyright © 2017 American Society for Microbiology.

Mesh:

Substances:

Year:  2017        PMID: 28404684      PMCID: PMC5442516          DOI: 10.1128/JCM.00430-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Emerging carbapenemases: a global perspective.

Authors:  Timothy R Walsh
Journal:  Int J Antimicrob Agents       Date:  2010-11       Impact factor: 5.283

2.  Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Authors:  Spyros Pournaras; Ioulia Kristo; Georgia Vrioni; Alexandros Ikonomidis; Aggeliki Poulou; Dimitra Petropoulou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

Review 3.  Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

Authors:  Y Carmeli; M Akova; G Cornaglia; G L Daikos; J Garau; S Harbarth; G M Rossolini; M Souli; H Giamarellou
Journal:  Clin Microbiol Infect       Date:  2010-02       Impact factor: 8.067

Review 4.  Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues.

Authors:  Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

5.  KPC screening by updated BD Phoenix and Vitek 2 automated systems.

Authors:  Kenneth S Thomson; Iraida E Robledo; Guillermo J Vázquez; Ellen S Moland
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

6.  Detection of Carbapenemase Genes in Aquatic Environments in Rio de Janeiro, Brazil.

Authors:  Carlos Felipe Machado de Araujo; Dalton Marcondes Silva; Marcos Tavares Carneiro; Sthefanie Ribeiro; Marcela Fontana-Maurell; Patricia Alvarez; Marise Dutra Asensi; Viviane Zahner; Ana Paula D'Alincourt Carvalho-Assef
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 7.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

8.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Transferable imipenem resistance in Pseudomonas aeruginosa.

Authors:  M Watanabe; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 10.  Treating infections caused by carbapenemase-producing Enterobacteriaceae.

Authors:  L S Tzouvelekis; A Markogiannakis; E Piperaki; M Souli; G L Daikos
Journal:  Clin Microbiol Infect       Date:  2014-07-12       Impact factor: 8.067

View more
  3 in total

1.  Staphylococcus aureus Resistance Patterns in Wisconsin: 2018 Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology (SWOTARE) Program Report.

Authors:  Rebecca H Schulte; Erik Munson
Journal:  Clin Med Res       Date:  2019-10-03

2.  Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates.

Authors:  Vicki Whitley; Susan Kircher; Tracey Gill; Janet A Hindler; Susan O'Rourke; Charles Cooper; Anagha Tulpule; Gerald A Denys
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

3.  High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases.

Authors:  Gina Thomson; David Turner; William Brasso; Susan Kircher; Thierry Guillet; Kenneth Thomson
Journal:  J Clin Microbiol       Date:  2017-10-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.